Biowest

Biowest is a well-established, privately-held European leader in the supply of essential biological components for the diagnostics and cell therapy sectors. The company operates a vertically integrated model, overseeing the entire process from the global collection of raw materials to final packaging, ensuring stringent quality, efficiency, and traceability. Its core product portfolio includes fetal bovine serum (FBS), other animal sera, bovine serum albumin (BSA), human serum and plasma, cell culture media, and ancillary reagents, serving research, diagnostic, and therapeutic manufacturing customers worldwide. With its strong certifications and batch-specific documentation, Biowest is positioned as a trusted partner in the bioproduction supply chain.

Vertically integrated platform for the sourcing, processing, quality testing, and traceable supply of biological raw materials (animal sera, human plasma, proteins, cell culture reagents) for life sciences and bioproduction.

Biowest competes in a global market with large players like Thermo Fisher Scientific (Gibco), Merck (Sigma-Aldrich), and GE Healthcare (Cytiva), as well as specialized serum suppliers. Its differentiation is based on deep European roots, strong vertical integration for traceability, and a focus on certified quality for regulated applications, rather than being the lowest-cost provider.